−1,070 KRW
−7.92 B KRW
897.03 M KRW
5.20 M
About GENESYSTEM CO., LTD
Sector
Industry
CEO
Yu-Jin Seo
Website
Headquarters
Daejeon
Founded
2010
ISIN
KR7363250002
FIGI
BBG010161V49
Genesystem Co., Ltd engages in providing PCR based molecular diagnostic products. Its products include GENECHECKER series of PCR platforms, SMARTCHEK molecular testing assays and MultiCHEK multiplex biochip products. The company was founded on March 24, 2010 and is headquartered in Daejeon, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 363250 is 8,640 KRW — it has decreased by −1.37% in the past 24 hours. Watch GENESYSTEM CO., LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENESYSTEM CO., LTD stocks are traded under the ticker 363250.
363250 stock has risen by 1.77% compared to the previous week, the month change is a −12.73% fall, over the last year GENESYSTEM CO., LTD has showed a 1.41% increase.
363250 reached its all-time high on Sep 8, 2023 with the price of 32,000 KRW, and its all-time low was 4,970 KRW and was reached on Oct 13, 2022. View more price dynamics on 363250 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
363250 stock is 14.35% volatile and has beta coefficient of 0.78. Track GENESYSTEM CO., LTD stock price on the chart and check out the list of the most volatile stocks — is GENESYSTEM CO., LTD there?
Today GENESYSTEM CO., LTD has the market capitalization of 58.84 B, it has decreased by −1.38% over the last week.
Yes, you can track GENESYSTEM CO., LTD financials in yearly and quarterly reports right on TradingView.
363250 net income for the last quarter is −1.72 B KRW, while the quarter before that showed −1.98 B KRW of net income which accounts for 12.75% change. Track more GENESYSTEM CO., LTD financial stats to get the full picture.
No, 363250 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 76.00 employees. See our rating of the largest employees — is GENESYSTEM CO., LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENESYSTEM CO., LTD EBITDA is −8.40 B KRW, and current EBITDA margin is −996.53%. See more stats in GENESYSTEM CO., LTD financial statements.
Like other stocks, 363250 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENESYSTEM CO., LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENESYSTEM CO., LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENESYSTEM CO., LTD stock shows the strong sell signal. See more of GENESYSTEM CO., LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.